Clinical Trials Directory

Trials / Conditions / Urinary Urgency

Urinary Urgency

14 registered clinical trials studyying Urinary Urgency4 currently recruiting.

StatusTrialSponsorPhase
RecruitingAPPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
NCT06797245
Medstar Health Research InstituteN/A
Not Yet RecruitingOptimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a Inject
NCT06695585
University of LouisvillePhase 4
Not Yet RecruitingOptimal Injection Interval for Intra-Detrusor Botulinum Toxin
NCT06483217
Louisiana State University Health Sciences Center in New OrleansN/A
CompletedIntradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial
NCT05308979
University of California, IrvinePhase 4
RecruitingBTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder
NCT04873037
Corewell Health EastN/A
CompletedFREEOAB Study for Overactive Bladder
NCT04547920
Avation Medical, Inc.N/A
TerminatedGroup Medical Visits for Latina Women With Urgency Urinary Incontinence
NCT03687164
University of Southern CaliforniaN/A
CompletedEnhancing Behavioral Treatment for Women With Pelvic Floor Disorders
NCT03623880
Northwestern UniversityN/A
TerminatedOnabotulinumtoxinA Bladder Injection Study
NCT03523091
Corewell Health EastPhase 4
CompletedFluids Affecting Bladder Urgency and Lower Urinary Symptoms
NCT03625492
University of MichiganN/A
CompletedCurcumin and Piperine in Reducing Inflammation for Ureteral Stent-Induced Symptoms in Patients With Cancer
NCT02598726
Mayo ClinicPhase 1
CompletedEfficacy and Safety of Gabapentin in Treating Overactive Bladder
NCT01486706
Michael E. ChuaPhase 2 / Phase 3
UnknownEvaluation of Solifenacin in the Treatment of OAB Symptoms in Patients Who Have Successfully Undergone GreenLi
NCT00826527
Seattle Urology Research CenterPhase 4
TerminatedRefractory Urge Incontinence and Botox Injections
NCT00373789
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Phase 3